
Fresenius Medical Care AG & Co. KGaA
FMS
Updated: 25/09/2026, 01:57:53
Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides comprehensive training, and offers ongoing patient assistance, including clinical oversight and coordinating supply deliveries directly to patients. In the United States, Fresenius Medical Care also contracts with hospitals to provide vital dialysis interventions for hospitalized individuals suffering from end-stage renal disease (ESRD) and acute kidney failure. Beyond services, it is a prominent developer, manufacturer, and distributor of a broad range of dialysis products. This portfolio encompasses polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers and solutions, concentrates, bloodlines, renal pharmaceuticals, and water treatment systems. Additionally, the company produces non-dialysis medical devices, including acute cardiopulmonary and apheresis products. Its pharmaceutical division focuses on developing, acquiring, and in-licensing specialized renal medications, distributing these essential drugs and supplies to both individual patients' homes and dialysis centers. The company also extends its medical offerings to include a variety of specialized services such as vascular, cardiovascular, and endovascular care, operating ambulatory surgery centers for vascular procedures, and providing physician services in nephrology and cardiology. Products are sold directly to dialysis clinics, hospitals, and specialized treatment centers, complemented by sales through local teams, independent distributors, dealers, and agents. By February 23, 2022, Fresenius Medical Care managed an impressive network of 4,171 outpatient dialysis clinics across roughly 150 countries. Established in 1996, the company maintains its headquarters in Bad Homburg, Germany.
No summaries found.
- Share price
- $22.35
- Market cap
- $12.00B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Helen Giza
- Employees
- 108,165
- IPO date
- 17/09/1996
- Beta
- 0.739
- Last dividend
- $0.00
- Day range
- $22.19 – $22.44
- 52-week range
- $20.02 – $27.64
- 1-day performance
- -0.27%
- 1-year performance
- 11.64%
- Current drawdown (1Y)
- -19.14%
- CIK
- 0001333141
- CUSIP
- 358029106
- ISIN
- US3580291066
- Created
- 07/12/2025, 04:02:54
- Last update
- 25/09/2026, 01:57:53
Track Fresenius Medical Care AG & Co. KGaA with an AI analyst
See which prediction-market events move FMS, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Toronto Stock Exchange, Focus Graphite Inc., The View from the C-Suite
Newsfile Corp • STOCK • 21/05/2026, 17:01:00
FMS Stock Rises Despite Q1 Earnings & Sales Miss, Margins Expand
Zacks Investment Research • STOCK • 06/05/2026, 14:41:15
Fresenius Medical Care (NYSE: FMS) Navigates Strategic Transformation Amidst Quarterly Earnings
Market Data • Market Data • 05/05/2026, 23:05:52
Fresenius Medical: The Undervaluation Is Getting Clearer
Seeking Alpha • STOCK • 05/05/2026, 14:09:52
Fresenius Medical Care Posts Lower Net Profit on One-Off Costs
WSJ • STOCK • 05/05/2026, 05:22:00
Fresenius Medical Care's revenue falls in Q1 as weak dollar takes toll
Reuters • STOCK • 05/05/2026, 03:08:57
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Zacks Investment Research • STOCK • 09/04/2026, 12:40:53
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
Zacks Investment Research • STOCK • 25/03/2026, 13:16:12
Fresenius (FMS) is a Top-Ranked Value Stock: Should You Buy?
Zacks Investment Research • STOCK • 24/03/2026, 11:41:31
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand
Zacks Investment Research • STOCK • 25/02/2026, 15:55:57
Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript
Seeking Alpha • STOCK • 24/02/2026, 16:47:53
Fresenius Medical Care's operating profit surges in Q4
Reuters • STOCK • 24/02/2026, 02:08:29